Buccal Midazolam and Rectal Diazepam for acute management

Type: drug

Status: FDA Approved (for acute repetitive seizures, off-label for febrile seizures but standard of care)

Developer: Multiple pharmaceutical companies

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026